6KJ-14281-26016
3 vaccinations
3 coded responses
21 check-ins
3 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 930 / CA
- Registered
- 2022-08-21
- Relationship
- Child or adolescent in my care
- Guardian
- HSC-25387-57799
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-08-18
Dose 1 — Pfizer-BioNTech
-
2022-08-21
Registered in v-safe
- 2022-08-21
- 2022-08-23
- 2022-08-24
- 2022-08-25
- 2022-09-01
-
2022-09-08
Dose 2 — Pfizer-BioNTechCo-administered: Flu:Hepatitis A
- 2022-09-08
- 2022-09-09
- 2022-09-10
- 2022-09-11
-
2022-09-12
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: GoodFree text: Runny nose/congestionMedDRA releases: 2024-11 · check-in free text available
- 2022-09-13
- 2022-09-14
- 2022-09-17
- 2022-09-22
- 2022-09-29
- 2022-10-06
- 2022-10-13
-
2022-10-20
Survey response — day 42, dose 2, under 3MedDRA: Rhinorrhoea — Feeling: GoodFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-11-04
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2022-12-09
Survey response — 3 months, dose 2, under 3MedDRA: Cough, Croup infectious, Respiratory tract congestion — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Croup, cough, congestionMedDRA releases: 2024-11 · check-in free text available
-
2022-12-09
Report sent to call center — 3 months, dose 2, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
-
2022-12-12
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-03-09
- 2023-05-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-08-18 | Pfizer-BioNTech | No |
| 2 | 2022-09-08 | Pfizer-BioNTech | Flu:Hepatitis A |
| 3 | 2022-11-04 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-12-09 | Successful 2022-12-12 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 12 (Under 3) — days 1–6 daily, dose 2, under 3
Systemic reaction (other): Runny nose/congestion
Release 12 (Under 3) — day 42, dose 2, under 3
Symptoms: Runny nose
Release 12 (Under 3) — 3 months, dose 2, under 3
Symptoms: Croup, cough, congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Croup infectious | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Respiratory tract congestion | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release